November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Feb 24, 2024, 16:34

Chul Kim: What are other relevant targets for ADC therapy in NSCLC?

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter:

What are other relevant targets for Antibody Drug Conjugates (ADCs) therapy in Non-small cell lung cancer (NSCLC)? Farletuzumab ecteribulin (FRalpha), patritumab deruxtecan (HER3), SGN-B6A (integrin beta-6) are being actively investigated. Awesome talk by Maria Antonia Vélez (hematology/oncology fellow at UCLA)!”

Image

Source: Chul Kim/X